問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMS202359_0025
NCT Number(ClinicalTrials.gov Identfier)-
Completed

2023-11-01 - 2026-10-31

Phase I

Not yet recruiting4

ICD-10C47.0

Malignant neoplasm of peripheral nerves of head, face and neck

ICD-10C49.0

Malignant neoplasm of connective and soft tissue of head, face and neck

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9171.0

Malignant neoplasm of connective and other soft tissue of head, face and neck

-

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/17

Investigators and Locations

Principal Investigator Hui-Ching Wang Division of Hematology & Oncology
Kaohsiung Medical Univeristy Chung-Ho Memorial Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Muh-Hwa Yang Division of Hematology & Oncology
Taipei Veterans General Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Ching Yun Hsieh Division of Hematology & Oncology
China Medical University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator HUAI-CHENG HUANG
National Taiwan University Hospital

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    11 participants

  • Global

    40 participants

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB